Jazz Pharmaceuticals plc — Director's Dealing 2013

Mar 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-03-05

Reporting Person: COZADD BRUCE C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-04	Ordinary Shares	S	1000	$60.00	Disposed	577161	Direct
2013-03-05	Ordinary Shares	A	50000	—	Acquired	627161	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-05	Nonstatutory Stock Option (right to buy)	$59.13	A	123309	Acquired	2023-03-04	Ordinary Shares (123309)	Direct
2013-03-05	Incentive Stock Option (right to buy)	$59.13	A	1691	Acquired	2023-03-04	Ordinary Shares (1691)	Direct

Footnotes

F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, March 5, 2013.

F3: These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, March 5, 2013, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.